CD4 and AIDS: However, CD4+ T-cell deficiency persists in up to 40% of patients receiving ART, particularly those patients who commenced ART with a very low CD4+ T-cell count,3 and is associated with persistent immune activation and an increased risk of ‘serious non-AIDS events'.